Genoox founded in 2014 is a global company founded by an experienced team of geneticists, bioinformaticians, engineers and technology experts with a passion for life science, big data, high-performance computing and a clear vision to revolutionize the way genomic data is shared, stored and analyzed.

Genoox removes the final barrier to widespread adoption of clinical NGS, enabling personalized medicine for mainstream patients. Our platform is used in the diagnosis and treatment of genetic disorders and cancer, as well as new drug discovery and family planning. Genoox has an international footprint, with U.S. offices in Palo Alto, CA.